Miles K. Wandersee

Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus Infection

Michael P. Malakhov, Laura Aschenbrenner, Donald F. Smee et al. · Antimicrobial Agents and Chemotherapy · 2006 · 232 citations · Full text

Life Sciences, Infectious Diseases, Pharmaceutical Biotechnology +17

Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin

Yohichi Kumaki, Miles K. Wandersee, Aaron Smith et al. · Antiviral Research · 2011 · 91 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol® (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse model

Yohichi Kumaki, Andres Μ. Salazar, Miles K. Wandersee et al. · Antiviral Research · 2016 · 55 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Alpha-Amino-Beta-Carboxy-Muconate-Semialdehyde Decarboxylase Controls Dietary Niacin Requirements for NAD+ Synthesis

Laura Palzer, Jessica J. Bader, Frances Angel et al. · Cell Reports · 2018 · 53 citations · Full text

Life Sciences, Biochemistry, Nutritional Sciences +17

Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model

Yohichi Kumaki, Jane Ennis, Ramtin Rahbar et al. · Antiviral Research · 2010 · 51 citations

Life Sciences, Immunology, Infectious Diseases +16